JP2002519394A5 - - Google Patents

Info

Publication number

JP2002519394A5

JP2002519394A5 JP2000557884A JP2000557884A JP2002519394A5 JP 2002519394 A5 JP2002519394 A5 JP 2002519394A5 JP 2000557884 A JP2000557884 A JP 2000557884A JP 2000557884 A JP2000557884 A JP 2000557884A JP 2002519394 A5 JP2002519394 A5 JP 2002519394A5

Authority

JP

Japan

Prior art keywords

fragment

derivative

gdf

mammal

nucleic acid

Prior art date

1999-07-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 description 96
• 102000012946 Growth Differentiation Factor 1 Human genes 0.000 description 87
• 108010090296 Growth Differentiation Factor 1 Proteins 0.000 description 87
• 239000012634 fragment Substances 0.000 description 83
• 241000124008 Mammalia Species 0.000 description 63
• 150000007523 nucleic acids Chemical class 0.000 description 55
• 102000039446 nucleic acids Human genes 0.000 description 55
• 108020004707 nucleic acids Proteins 0.000 description 55
• 108090000742 Neurotrophin 3 Proteins 0.000 description 17
• 102000004230 Neurotrophin 3 Human genes 0.000 description 15
• 208000014674 injury Diseases 0.000 description 15
• 229940032018 neurotrophin 3 Drugs 0.000 description 15
• 230000008733 trauma Effects 0.000 description 15
• 210000000653 nervous system Anatomy 0.000 description 12
• 210000004556 brain Anatomy 0.000 description 11
• 230000004770 neurodegeneration Effects 0.000 description 11
• 208000033808 peripheral neuropathy Diseases 0.000 description 11
• 210000001328 optic nerve Anatomy 0.000 description 10
• 208000028867 ischemia Diseases 0.000 description 9
• 210000000278 spinal cord Anatomy 0.000 description 9
• 230000016273 neuron death Effects 0.000 description 8
• 208000006011 Stroke Diseases 0.000 description 7
• 230000007547 defect Effects 0.000 description 7
• 208000010125 myocardial infarction Diseases 0.000 description 7
• 208000032253 retinal ischemia Diseases 0.000 description 7
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 6
• 208000010412 Glaucoma Diseases 0.000 description 6
• 208000010496 Heart Arrest Diseases 0.000 description 6
• 230000017531 blood circulation Effects 0.000 description 6
• 230000030833 cell death Effects 0.000 description 6
• 230000007850 degeneration Effects 0.000 description 6
• 210000002569 neuron Anatomy 0.000 description 6
• 230000002980 postoperative effect Effects 0.000 description 6
• 230000002207 retinal effect Effects 0.000 description 6
• 108010025020 Nerve Growth Factor Proteins 0.000 description 5
• 102000007072 Nerve Growth Factors Human genes 0.000 description 5
• 230000000295 complement effect Effects 0.000 description 5
• 201000010099 disease Diseases 0.000 description 5
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
• 235000015097 nutrients Nutrition 0.000 description 5
• 208000024827 Alzheimer disease Diseases 0.000 description 4
• 201000010374 Down Syndrome Diseases 0.000 description 4
• 208000023105 Huntington disease Diseases 0.000 description 4
• 208000006264 Korsakoff syndrome Diseases 0.000 description 4
• 208000028389 Nerve injury Diseases 0.000 description 4
• 208000018737 Parkinson disease Diseases 0.000 description 4
• 206010044688 Trisomy 21 Diseases 0.000 description 4
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 4
• 230000007812 deficiency Effects 0.000 description 4
• 206010015037 epilepsy Diseases 0.000 description 4
• 230000008764 nerve damage Effects 0.000 description 4
• 208000015122 neurodegenerative disease Diseases 0.000 description 4
• 230000007823 neuropathy Effects 0.000 description 4
• 201000001119 neuropathy Diseases 0.000 description 4
• 201000006474 Brain Ischemia Diseases 0.000 description 3
• 208000013016 Hypoglycemia Diseases 0.000 description 3
• 206010021143 Hypoxia Diseases 0.000 description 3
• 230000002218 hypoglycaemic effect Effects 0.000 description 3
• 230000007954 hypoxia Effects 0.000 description 3
• 102100029268 Neurotrophin-3 Human genes 0.000 description 2
• 208000030768 Optic nerve injury Diseases 0.000 description 2
• 208000036982 Spinal cord ischaemia Diseases 0.000 description 2
• 210000001525 retina Anatomy 0.000 description 2
• 206010008120 Cerebral ischaemia Diseases 0.000 description 1
• 206010061216 Infarction Diseases 0.000 description 1
• 208000010038 Ischemic Optic Neuropathy Diseases 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• 206010008118 cerebral infarction Diseases 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 230000007574 infarction Effects 0.000 description 1
• 230000007971 neurological deficit Effects 0.000 description 1
• 235000016709 nutrition Nutrition 0.000 description 1